Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab
Vaccitech isn’t just going after one of the Holy Grails in biotech R&D. It’s taking aim at two of them. A spinout from some leading vaccine experts at Oxford’s Jenner Institute, the startup has been following up on new research to go after both a universal flu vaccine as well
Google backs M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab
Source: Virology News
